Intranasal Oxytocin for ObesityFranziska Plessow, Elizabeth A. Lawson, Julia Gydus et al.|NEJM Evidence|2024Cited by 20
Arginine-Vasopressin Dynamics in Relation to Food Intake and 8-Week Intranasal Oxytocin Treatment in Adults With ObesityAnna Aulinas, Elizabeth A. Lawson, Francesca Galbiati et al.|The Journal of Clinical Endocrinology & Metabolism|2025Cited by 2
7458 Eight Weeks Intranasal Oxytocin vs. Placebo Does Not Impact Circulating Oxytocin or Arginine-Vasopressin Levels in Adults With ObesityAnna Aulinas, Elizabeth A. Lawson, Francesca Galbiati et al.|Journal of the Endocrine Society|2024Cited by 0
SAT-051 Prolonged intranasal oxytocin treatment effects on reproductive hormones in adults with obesityFrancesca Galbiati, Elizabeth A. Lawson, Sarah Hiranandani et al.|Journal of the Endocrine Society|2025Cited by 0
Oxytocin levels do not change around a meal and correlate with reward‐driven caloric consumption in adults with obesityMarie‐Louis Wronski, Elizabeth A. Lawson, Regine Boutin et al.|Diabetes Obesity and Metabolism|2025Cited by 0